Results
Clinical trials included in 23 of the WRs have been concluded, 19 have
resulted in exclusivity, and 3 drugs that were studied have been
approved for use in pediatric populations. Herein we present the
spectrum of WRs from a regulatory, study design, dosing, formulation,
analysis plan, evidential standard of efficacy and safety perspective.